PMID- 20869343 OWN - NLM STAT- MEDLINE DCOM- 20110325 LR - 20221207 IS - 1878-0210 (Electronic) IS - 1878-0210 (Linking) VI - 4 IP - 4 DP - 2010 Dec TI - The relationship between socioeconomic deprivation and metabolic/cardiovascular risk factors in a cohort of patients with type 2 diabetes mellitus. PG - 241-9 LID - 10.1016/j.pcd.2010.08.004 [doi] AB - AIM: There is conflicting information on the impact of socioeconomic deprivation on outcomes in diabetes. Our aim was to study the relationship between socioeconomic deprivation and clinical outcome indicators in a patient cohort with type 2 diabetes mellitus [T2DM]. METHODS: We recruited a random sample of 446 patients with T2DM [57% male] stratified by Income Deprivation Measure. Data on patient specific socioeconomic status, educational attainment, behaviour and attitudes were gathered by patient interview. Data analysis was by logistic and linear regression with correction for age, gender and duration of diabetes. RESULTS: The study cohort showed high levels of deprivation with 80% reporting a household annual income of < pound20,000 and 69.5% having no formal educational qualification. The cohort was actively managed with high usage of lipid lowering [90.1%], antihypertensive [80.6%] and antiplatelet agents [78%] and correspondingly good control of modifiable risk factors: HbA1c 7.6 [1.4]%, systolic blood pressure 134.2 [20.6], diastolic blood pressure 72.7 [11.2]mmHg, total cholesterol 4.0 [0.9]mmol/L. Socioeconomic disadvantage was strongly related to measures of integration and attitude to diabetes. Despite this there were no significant or consistent relationships between Income Deprivation Measure/self-reported annual household income/educational attainment on metabolic or cardiovascular risk factors. CONCLUSIONS: Successful management of modifiable risk factors can be achieved in a way that is independent of socioeconomic position. CI - Copyright (c) 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved. FAU - O'Kane, Maurice J AU - O'Kane MJ AD - Diabetes Clinic, Altnagelvin Hospital, Londonderry, Northern Ireland, United Kingdom. Maurice.OKane@westerntrust.hscni.net FAU - McMenamin, Mary AU - McMenamin M FAU - Bunting, Brendan P AU - Bunting BP FAU - Moore, Adrian AU - Moore A FAU - Coates, Vivien E AU - Coates VE LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Prim Care Diabetes JT - Primary care diabetes JID - 101463825 RN - 0 (Antihypertensive Agents) RN - 0 (Biomarkers) RN - 0 (Glycated Hemoglobin A) RN - 0 (Hypoglycemic Agents) RN - 0 (Hypolipidemic Agents) RN - 0 (Platelet Aggregation Inhibitors) RN - 0 (hemoglobin A1c protein, human) RN - 97C5T2UQ7J (Cholesterol) SB - IM MH - Antihypertensive Agents/therapeutic use MH - Biomarkers/blood MH - Blood Pressure MH - Cardiovascular Diseases/blood/epidemiology/physiopathology/*prevention & control MH - Cholesterol/blood MH - Cohort Studies MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/blood/*drug therapy/epidemiology/physiopathology MH - Female MH - Glycated Hemoglobin/analysis MH - Health Knowledge, Attitudes, Practice MH - Humans MH - Hypoglycemic Agents/therapeutic use MH - Hypolipidemic Agents/therapeutic use MH - Linear Models MH - Logistic Models MH - Male MH - Metabolic Syndrome/blood/*drug therapy/epidemiology/physiopathology MH - Northern Ireland/epidemiology MH - Outpatient Clinics, Hospital MH - Platelet Aggregation Inhibitors/therapeutic use MH - *Poverty MH - Registries MH - Risk Assessment MH - Risk Factors MH - *Socioeconomic Factors EDAT- 2010/09/28 06:00 MHDA- 2011/03/26 06:00 CRDT- 2010/09/28 06:00 PHST- 2010/04/01 00:00 [received] PHST- 2010/08/13 00:00 [revised] PHST- 2010/08/19 00:00 [accepted] PHST- 2010/09/28 06:00 [entrez] PHST- 2010/09/28 06:00 [pubmed] PHST- 2011/03/26 06:00 [medline] AID - S1751-9918(10)00115-4 [pii] AID - 10.1016/j.pcd.2010.08.004 [doi] PST - ppublish SO - Prim Care Diabetes. 2010 Dec;4(4):241-9. doi: 10.1016/j.pcd.2010.08.004.